Titre (en)
Exploration
Accueil
Racine
Exploration
Accueil

Serveur d'exploration COVID et hydrochloroquine - Exploration (Accueil)

Index « Titre (en) » - entrée « emergency »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
emergencies < emergency < emerging  Facettes :

List of bibliographic references indexed by emergency

Number of relevant bibliographic references: 17.
Ident.Authors (with country if any)Title
000495 (2021) John G. Rizk [États-Unis] ; Donald N. Forthal [États-Unis] ; Kamyar Kalantar-Zadeh [États-Unis] ; Mandeep R. Mehra [États-Unis] ; Carl J. Lavie [États-Unis] ; Youssef Rizk [Liban] ; Joann P. Pfeiffer [États-Unis] ; John C. Lewin [États-Unis]Expanded Access Programs, compassionate drug use, and Emergency Use Authorizations during the COVID-19 pandemic.
000941 (2020) Nihan K [Turquie] ; Canan Özlü [Turquie] ; Hatice Karao Lu Asrak [Turquie] ; Rem Ceren Erba [Turquie] ; Ay E Çak L Güzin [Turquie] ; Gizem Atakul [Turquie] ; Özge Atay [Turquie] ; Özgür Appak [Turquie] ; Ayça Arzu Say Ner [Turquie] ; Nevin Uzuner [Turquie] ; Suna Asilsoy [Turquie] ; Nur En Belet [Turquie] ; Duygül Y Lmaz [Turquie] ; Murat Duman [Turquie][Evaluation of SARS-CoV-2 PCR Positive Cases in the Pediatric Emergency Department].
000D19 (2020) Jean W. Liew [États-Unis] ; Elizabeth R. Graef [États-Unis] ; Jeffrey A. Sparks [États-Unis] ; Alfred Hyoungju Kim [États-Unis]Response to: 'Emergency arising from patients' fear of taking antimalarials during these COVID-19 times: are antimalarials as unsafe for cardiovascular health as recent reports suggest?' by Santos-Moreno et al.
000E56 (2020) Nikita Mehta [États-Unis] ; Maryann Mazer-Amirshahi [États-Unis] ; Nour Alkindi [États-Unis] ; Ali Pourmand [États-Unis]Pharmacotherapy in COVID-19; A narrative review for emergency providers.
000F02 (2020) Andrea Ciorba [Italie] ; Piotr Henryk Skar Y Ski [Pologne] ; Stefano Pelucchi [Italie] ; Stavros Hatzopoulos [Italie]Ototoxicity prevention during the SARS-CoV-2 (COVID-19) emergency.
000F37 (2020) Mike Z. Zhai [États-Unis] ; Carolyn T. Lye [États-Unis] ; Aaron S. Kesselheim [États-Unis]Need for Transparency and Reliable Evidence in Emergency Use Authorizations for Coronavirus Disease 2019 (COVID-19) Therapies.
000F75 (2020) Tony Y. Zhang [République populaire de Chine] ; Boyu Zhong [République populaire de Chine]Meeting the potential emergency global drug supply challenge of hydroxychloroquine for COVID-19.
001277 (2020) Louis Larrouquere [France] ; Manon Gabin [France] ; Emmanuelle Poingt [France] ; Amelle Mouffak [France] ; Alex Hlavaty [France] ; Marion Lepelley [France] ; Charles Khouri [France] ; Alexandre Bellier [France] ; Joachim Alexandre [France] ; Pierrick Bedouch [France] ; Laurent Bertoletti [France] ; Regis Bordet [France] ; Béatrice Bouhanick [France] ; Annie-Pierre Jonville-Bera [France] ; Silvy Laporte [France] ; Claire Le Jeunne [France] ; Louis Letinier [France] ; Joëlle Micallef [France] ; Florian Naudet [France] ; Matthieu Roustit [France] ; Mathieu Molimard [France] ; Vincent Richard [France] ; Jean-Luc Cracowski [France]Genesis of an emergency public drug information website by the French Society of Pharmacology and Therapeutics during the COVID-19 pandemic.
001307 (2020) Roy Guharoy ; Edward P. KrenzelokFDA Emergency Use Authorization: Glass Half Empty?
001338 (2020) Pedro Santos-Moreno [Oman] ; Diana Buitrago-Garcia [Colombie] ; Laura Villarreal [Colombie] ; Anggie Aza [Colombie] ; Michael Cabrera [Colombie] ; Wilberto Rivero [Colombie] ; Adriana Rojas-Villarraga [Colombie]Emergency arising from patients' fear of taking antimalarials during these COVID-19 times: are antimalarials as unsafe for cardiovascular health as recent reports suggest?
001339 (2020) Kyle Thomson [États-Unis] ; Herschel Nachlis [États-Unis]Emergency Use Authorizations During the COVID-19 Pandemic: Lessons From Hydroxychloroquine for Vaccine Authorization and Approval.
001340 (2020) Christopher R. Piszczatoski [États-Unis] ; Jason Powell [États-Unis]Emergency Authorization of Chloroquine and Hydroxychloroquine for Treatment of COVID-19.
001427 (2020) Natalia Doudka [France] ; Madeleine Giocanti [France] ; Manon Basso [France] ; Renée Ugdonne [France] ; Karine Barthelemy [France] ; Bruno Lacarelle [France] ; Olivier Blin [France] ; Caroline Solas [France] ; Romain Guilhaumou [France]Development and validation of a simple and rapid UHPLC-MS/MS method for the quantification of hydroxychloroquine in plasma and blood samples in the emergency context of SARS-CoV-2 pandemic.
001462 (2020) Jeanne LenzerCovid-19: US gives emergency approval to hydroxychloroquine despite lack of evidence.
001823 (2020) CORRIGENDUM to Emergency Approval of Chloroquine and Hydroxychloroquine for Treatment of COVID-19 (updated to Emergency Authorization of Chloroquine and Hydroxychloroquine for Treatment of COVID-19).
001830 (2020) Deborah Doroshow ; Scott Podolsky ; Justin BarrBiomedical Research in Times of Emergency: Lessons From History.
001948 (2020) Alessandra Della Porta [États-Unis] ; Kasha Bornstein [États-Unis] ; Austin Coye [États-Unis] ; Tim Montrief [États-Unis] ; Brit Long [États-Unis] ; Mehruba Anwar Parris [États-Unis]Acute chloroquine and hydroxychloroquine toxicity: A review for emergency clinicians.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i -k "emergency" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i  \
                -Sk "emergency" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidChloroV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Title.i
   |clé=    emergency
}}
Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021